Schedule 13G ownership disclosure
ELEDON PHARMACEUTICALS INC COM
Common Stock · CUSIP: 28617K101
Event date: 2025-06-30
- Filing-level shares
- 3,318,383
- Percent of class
- 5.54%
- The Vanguard Group
Shares: 3,318,383 · Class: 5.54%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000874
- Form type
- SCHEDULE 13G
- Filer
- Eledon Pharmaceuticals, Inc.
- CIK
- CIK 1404281
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership